scholarly article | Q13442814 |
P50 | author | Hatem A El-Mezayen | Q83326709 |
Aziza B Shalby | Q83395249 | ||
Wafaa Gh Shousha | Q85092617 | ||
Nadia S Mahmoud | Q91268539 | ||
Hanaa H Ahmed | Q59160184 | ||
P2093 | author name string | Nora N Ismaiel | |
P2860 | cites work | Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells | Q33402834 |
Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue | Q33866433 | ||
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications | Q33899708 | ||
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation | Q34338138 | ||
Proliferating cell nuclear antigen (PCNA): ringmaster of the genome | Q34420568 | ||
Serum tumor markers for detection of hepatocellular carcinoma | Q34501851 | ||
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence | Q34630306 | ||
Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities | Q73671348 | ||
Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum | Q79094780 | ||
Vitamin E and atherosclerosis | Q80502804 | ||
Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma | Q83069124 | ||
Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats | Q83950749 | ||
Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats | Q84860552 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Mitochondrial effectors in caspase-independent cell death | Q35637415 | ||
Gene expression of gamma-glutamyltranspeptidase | Q36363180 | ||
Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway | Q36763380 | ||
Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death. | Q36892623 | ||
Cancer chemoprevention: a rapidly evolving field. | Q37003415 | ||
Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma | Q37099380 | ||
Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences | Q37238526 | ||
NF-kappaB signaling, liver disease and hepatoprotective agents | Q37302741 | ||
Effects of curcumin on ion channels and transporters | Q37629713 | ||
Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma | Q39001010 | ||
Curcumin inhibits MHCC97H liver cancer cells by activating ROS/TLR-4/caspase signaling pathway | Q39005930 | ||
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients | Q39089577 | ||
Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo | Q39270373 | ||
2 Mechanisms of Toxic Action | Q40027677 | ||
Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. | Q40097587 | ||
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. | Q40144497 | ||
Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol | Q40347562 | ||
Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis | Q40394920 | ||
The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells. | Q40459879 | ||
Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. | Q40515765 | ||
Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide | Q40910373 | ||
Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients | Q41902323 | ||
A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. | Q42054722 | ||
Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: myrrh (Commiphora molmol) vs. turmeric (Curcuma longa). | Q42493476 | ||
Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats | Q43100399 | ||
Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice. | Q43605068 | ||
Expression and role of Bcl-xL in human hepatocellular carcinomas | Q43657681 | ||
Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. | Q43724491 | ||
Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing | Q43798027 | ||
Suppression of altered hepatic foci development by curcumin in wistar rats | Q44468736 | ||
Immunomodulatory effect of Stichopus japonicus acid mucopolysaccharide on experimental hepatocellular carcinoma in rats. | Q44893657 | ||
Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. | Q44934094 | ||
Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma | Q46482187 | ||
Antioxidant and radical scavenging properties of curcumin | Q46545266 | ||
Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats | Q46594884 | ||
Dynamic expression of rat heat shock protein gp96 and its gene during development of hepatocellular carcinoma | Q46845443 | ||
Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats | Q48599517 | ||
Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. | Q51713756 | ||
Cell biology. Stress response and aging. | Q51811865 | ||
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. | Q53414005 | ||
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats | Q58215294 | ||
Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells | Q71405348 | ||
P433 | issue | 3 | |
P921 | main subject | curcumin | Q312266 |
P304 | page(s) | 1667-1678 | |
P577 | publication date | 2014-11-05 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model | |
P478 | volume | 36 |
Search more.